Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Eur J Epidemiol ; 21(7): 559-60, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16830171

RESUMO

Tattooing and body piercing may be visible markers to identify adolescents whose lifestyle may put them at a higher risk for morbidity and mortality. In 664 Brazilian adolescents we found 8.4% of body modifications. Further, sexual experience, illicit drug, alcohol consumption, and anti-HBc positivity were independently associated with them. These data suggest the potential risk of tattooing/body piercing in our youths.


Assuntos
Comportamento do Adolescente/psicologia , Piercing Corporal , Estilo de Vida , Assunção de Riscos , Tatuagem , Adolescente , Brasil , Humanos , Entrevistas como Assunto , Medição de Risco
2.
Mem Inst Oswaldo Cruz ; 101(3): 251-6, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16862317

RESUMO

In order to evaluate the seroepidemiology and response to Butang vaccine in adolescents from low income families in Central Brazil, blood samples of 664 adolescents were tested for hepatitis B surface antigen (HBsAg), hepatitis B core antibody (anti-HBc), and hepatitis B surface antibody (anti-HBs) markers, and multiple logistical regression analysis was carried out to determine variables associated with hepatitis B virus (HBV) infection markers. further, three 20 microg Butang vaccine doses were offered to all susceptible individuals (n = 304). Among those who accepted them (n = 182), the seroresponse was evaluated in 170 individuals by quantitative anti-HBs. an overall hbv prevalence of 5.9% was found: four adolescents were HBsAg positive, 24 were anti-HBc, anti-HBs-reactive, and 11 were anti-HBc only. The analyse of risk factors showed that age 16-19 years, place of birth outside Goiás, school B and body piercing were statistically associated with HBV infection markers (p < 0.05). All 170 adolescents responded to Butang, and a geometric mean titer (gmt) of 4344 mUI/ml was obtained. these results reinforce the importance of hepatitis b vaccine in adolescents despite of the hbv regional endemicity, and suggest that three doses of 20 microg of the Butang should guarantee protective anti-hbs levels to individuals at a critical time for hepatitis b acquiring such as latter adolescence and adulthood.


Assuntos
Anticorpos Anti-Hepatite B/sangue , Antígenos do Núcleo do Vírus da Hepatite B/sangue , Antígenos de Superfície da Hepatite B/sangue , Vacinas contra Hepatite B , Vírus da Hepatite B/imunologia , Hepatite B/epidemiologia , Adolescente , Adulto , Brasil/epidemiologia , Ensaio de Imunoadsorção Enzimática , Feminino , Hepatite B/diagnóstico , Hepatite B/imunologia , Humanos , Masculino , Pobreza , Prevalência , Análise de Regressão , Fatores de Risco , Estudos Soroepidemiológicos
3.
Mem. Inst. Oswaldo Cruz ; 101(3): 251-256, May 2006. tab, graf
Artigo em Inglês | LILACS | ID: lil-431721

RESUMO

In order to evaluate the seroepidemiology and response to Butang® vaccine in adolescents from low income families in Central Brazil, blood samples of 664 adolescents were tested for hepatitis B surface antigen (HBsAg), hepatitis B core antibody (anti-HBc), and hepatitis B surface antibody (anti-HBs) markers, and multiple logistical regression analysis was carried out to determine variables associated with hepatitis B virus (HBV) infection markers. further, three 20 µg butang® vaccine doses were offered to all susceptible individuals (n = 304). Among those who accepted them (n = 182), the seroresponse was evaluated in 170 individuals by quantitative anti-HBs. an overall hbv prevalence of 5.9 percent was found: four adolescents were HBsAg positive, 24 were anti-HBc, anti-HBs-reactive, and 11 were anti-HBc only. The analyse of risk factors showed that age 16-19 years, place of birth outside Goiás, school B and body piercing were statistically associated with HBV infection markers (p < 0.05). All 170 adolescents responded to butang®, and a geometric mean titer (gmt) of 4344 mui/ml was obtained. these results reinforce the importance of hepatitis b vaccine in adolescents despite of the hbv regional endemicity, and suggest that three doses of 20 µg of the butang® should guarantee protective anti-hbs levels to individuals at a critical time for hepatitis b acquiring such as latter adolescence and adulthood.


Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Anticorpos Anti-Hepatite B/sangue , Antígenos de Superfície da Hepatite B/sangue , Antígenos do Núcleo do Vírus da Hepatite B/sangue , Vacinas contra Hepatite B , Hepatite B/epidemiologia , Vírus da Hepatite B/imunologia , Brasil/epidemiologia , Ensaio de Imunoadsorção Enzimática , Hepatite B/diagnóstico , Hepatite B/imunologia , Pobreza , Prevalência , Análise de Regressão , Fatores de Risco , Estudos Soroepidemiológicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA